Tumors derived from the same cell type and having similar morphology may nevertheless have a distinctly different clinical behavior and response to therapy. Differences in the genetic lesions in these tumors, as reflected by their gene expression profiles, will provide insight into the mechanisms underlying the divergent clinical spectrum that is observed. Comparative genomic hybridization (CGH) and spectral karyotyping (SKY) are highly complementary novel techniques that examine the entire genome for genetic abnormalities and can supplement and extend conventional cytogenetic studies. In addition, the recently - developed high-density cDNA microarray technology is a very promising method for displaying the pattern of gene expression in tumor tissues. These powerful technologies with their associated informatic systems are now available for translational research. In order to evaluate the information generated by these technologies, an adequate number of well-characterized tumors with detailed clinical data must be available. We propose a multi-institutional, comprehensive molecular analysis of a large series of B-cell non-Hodgkin's lymphoma (NHL). The molecular data obtained will be correlated with the clinical and pathologic information in the extensive databases kept at our institutions to identify clinically and biologically distinct subsets of B- NHL. When unique molecular profiles of clinical and biological significance are identified, we will then define which components within each profile are essential determinants of the clinical features and outcome. Specific confirmatory assays for the expression of key genes, and the cytogenetic abnormalities involving these genes, will be performed. Our longer term goal is to use this information to design a simpler and less expensive microarray for diagnostic use. This """"""""diagnostic chip"""""""" could provide rapid molecular characterization of every B-NHL at presentation for optimal treatment decisions and prognostication. We also anticipate the identification of new and significant genetic alterations that will contribute to our understanding of the key events in neoplastic transformation and tumor progression. The insights gained from this project may also identify novel targets for preventive and therapeutic interventions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01CA084967-05S1
Application #
6946279
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Jacobson, James W
Project Start
1999-09-30
Project End
2005-06-30
Budget Start
2003-09-23
Budget End
2005-06-30
Support Year
5
Fiscal Year
2004
Total Cost
$54,140
Indirect Cost
Name
University of Nebraska Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Hassan, Hesham M; Varney, Michelle L; Jain, Smrati et al. (2014) Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ?Np73 expression in follicular lymphoma. Leuk Lymphoma 55:2924-31
Oricchio, Elisa; Ciriello, Giovanni; Jiang, Man et al. (2014) Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. J Exp Med 211:1379-91
Hassan, H M; Dave, B J; Singh, R K (2014) TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management. Curr Mol Med 14:432-9
Deffenbacher, Karen E; Iqbal, Javeed; Sanger, Warren et al. (2012) Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. Blood 119:3757-66
Cairns, Rob A; Iqbal, Javeed; Lemonnier, Francois et al. (2012) IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 119:1901-3
Geng, Huimin; Iqbal, Javeed; Chan, Wing C et al. (2011) Virtual CGH: an integrative approach to predict genetic abnormalities from gene expression microarray data applied in lymphoma. BMC Med Genomics 4:32
Dave, Bhavana J; Nelson, Marilu; Sanger, Warren G (2011) Lymphoma cytogenetics. Clin Lab Med 31:725-61, x-xi
Rimsza, Lisa M; Wright, George; Schwartz, Mark et al. (2011) Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues. Clin Cancer Res 17:3727-32
Wang, Xiao-Ming; Greiner, Timothy C; Bibikova, Marina et al. (2010) Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations. J Cell Biochem 109:818-27
Deffenbacher, Karen E; Iqbal, Javeed; Liu, Zhongfeng et al. (2010) Recurrent chromosomal alterations in molecularly classified AIDS-related lymphomas: an integrated analysis of DNA copy number and gene expression. J Acquir Immune Defic Syndr 54:18-26

Showing the most recent 10 out of 75 publications